VEGFB/VEGFR1-Induced Expansion of Adipose Vasculature Counteracts Obesity and Related Metabolic Complications

Cell Metabolism

Volumn 23, Issue 4, 2016, Pages 712-724

  Robciuc, Marius R ^a   Kivelä, Riikka ^a   Williams, Ian M ^b   De Boer, Jan Freark ^c   Van Dijk, Theo H ^c   Elamaa, Harri ^d   Tigistu Sahle, Feven ^a   Molotkov, Dmitry ^a   Leppänen, Veli Matti ^a   Käkelä, Reijo ^a   Eklund, Lauri ^d   Wasserman, David H ^b   Groen, Albert K ^c   Alitalo, Kari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; MESSENGER RNA; UNCOUPLING PROTEIN 1; VASCULOTROPIN B; VASCULOTROPIN RECEPTOR 1; KDR PROTEIN, MOUSE; VASCULOTROPIN RECEPTOR 2;

ADIPOSE TISSUE BLOOD FLOW; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; CAPILLARY DENSITY; COMPARATIVE STUDY; CONTROLLED STUDY; DIET INDUCED OBESITY; FATTY ACID TRANSPORT; GENE DELETION; GENE EXPRESSION; GENETIC TRANSDUCTION; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; INSULIN SENSITIVITY; LIPID STORAGE; MALE; METABOLIC BALANCE; METABOLIC DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE EXPANSION; VASCULAR REMODELING; VIRAL GENE DELIVERY SYSTEM; WEIGHT REDUCTION; ADIPOSE TISSUE; ANGIOGENESIS; ANIMAL; C57BL MOUSE; COMPLICATION; METABOLISM; OBESITY; PATHOLOGY; VASCULARIZATION;

ADIPOSE TISSUE; ANIMALS; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; OBESITY; VASCULAR ENDOTHELIAL GROWTH FACTOR B; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84963699473     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2016.03.004     Document Type: Article

References (52)

1. K. Aase, G. von Euler, X. Li, A. Pontén, P. Thorén, R. Cao, Y. Cao, B. Olofsson, S. Gebre-Medhin, M. Pekny, and et al. Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect Circulation 104 2001 358 364
2. A. Anisimov, V.M. Leppänen, D. Tvorogov, G. Zarkada, M. Jeltsch, T. Holopainen, S. Kaijalainen, and K. Alitalo The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands Sci. Signal. 6 2013 ra52
3. J.E. Ayala, D.P. Bracy, O.P. McGuinness, and D.H. Wasserman Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse Diabetes 55 2006 390 397
4. J.E. Ayala, D.P. Bracy, C. Malabanan, F.D. James, T. Ansari, P.T. Fueger, O.P. McGuinness, and D.H. Wasserman Hyperinsulinemic-euglycemic clamps in conscious, unrestrained mice J. Vis. Exp. 57 2011 e3188
5. T. Baba, K. Shimada, S. Neugebauer, D. Yamada, S. Hashimoto, and T. Watanabe The oral insulin sensitizer, thiazolidinedione, increases plasma vascular endothelial growth factor in type 2 diabetic patients Diabetes Care 24 2001 953 954
6. A. Bartelt, and J. Heeren Adipose tissue browning and metabolic health Nat. Rev. Endocrinol. 10 2014 24 36
7. D. Bellomo, J.P. Headrick, G.U. Silins, C.A. Paterson, P.S. Thomas, M. Gartside, A. Mould, M.M. Cahill, I.D. Tonks, S.M. Grimmond, and et al. Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia Circ. Res. 86 2000 E29 E35
8. J.S. Bonner, L. Lantier, C.M. Hasenour, F.D. James, D.P. Bracy, and D.H. Wasserman Muscle-specific vascular endothelial growth factor deletion induces muscle capillary rarefaction creating muscle insulin resistance Diabetes 62 2013 572 580
9. M. Bry, R. Kivelä, T. Holopainen, A. Anisimov, T. Tammela, J. Soronen, J. Silvola, A. Saraste, M. Jeltsch, P. Korpisalo, and et al. Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation Circulation 122 2010 1725 1733
10. M. Bry, R. Kivelä, V.M. Leppänen, and K. Alitalo Vascular endothelial growth factor-B in physiology and disease Physiol. Rev. 94 2014 779 794
11. A.S. Chung, and N. Ferrara Developmental and pathological angiogenesis Annu. Rev. Cell Dev. Biol. 27 2011 563 584
12. M.J. Cudmore, P.W. Hewett, S. Ahmad, K.Q. Wang, M. Cai, B. Al-Ani, T. Fujisawa, B. Ma, S. Sissaoui, W. Ramma, and et al. The role of heterodimerization between VEGFR-1 and VEGFR-2 in the regulation of endothelial cell homeostasis Nat. Commun. 3 2012 972
13. Y. Devaux, M. Vausort, F. Azuaje, M. Vaillant, M.L. Lair, E. Gayat, J. Lassus, L.L. Ng, D. Kelly, D.R. Wagner, and I.B. Squire Low levels of vascular endothelial growth factor B predict left ventricular remodeling after acute myocardial infarction J. Card. Fail. 18 2012 330 337
14. M.H. Dijkstra, E. Pirinen, J. Huusko, R. Kivelä, D. Schenkwein, K. Alitalo, and S. Ylä-Herttuala Lack of cardiac and high-fat diet induced metabolic phenotypes in two independent strains of Vegf-b knockout mice Sci. Rep. 4 2014 6238
15. I. Elias, S. Franckhauser, T. Ferré, L. Vilà, S. Tafuro, S. Muñoz, C. Roca, D. Ramos, A. Pujol, E. Riu, and et al. Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance Diabetes 61 2012 1801 1813
16. O. Gealekman, A. Burkart, M. Chouinard, S.M. Nicoloro, J. Straubhaar, and S. Corvera Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production Am. J. Physiol. Endocrinol. Metab. 295 2008 E1056 E1064
17. C.K. Glass, and J.M. Olefsky Inflammation and lipid signaling in the etiology of insulin resistance Cell Metab. 15 2012 635 645
18. I.J. Goldberg, R.H. Eckel, and N.A. Abumrad Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways J. Lipid Res. 50 Suppl 2009 S86 S90
19. C.E. Hagberg, A. Falkevall, X. Wang, E. Larsson, J. Huusko, I. Nilsson, L.A. van Meeteren, E. Samen, L. Lu, M. Vanwildemeersch, and et al. Vascular endothelial growth factor B controls endothelial fatty acid uptake Nature 464 2010 917 921
20. C.E. Hagberg, A. Mehlem, A. Falkevall, L. Muhl, B.C. Fam, H. Ortsäter, P. Scotney, D. Nyqvist, E. Samén, L. Lu, and et al. Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes Nature 490 2012 426 430
21. M. Harms, and P. Seale Brown and beige fat: development, function and therapeutic potential Nat. Med. 19 2013 1252 1263
22. D.I. Holmes, and I. Zachary The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease Genome Biol. 6 2005 209
23. J. Huusko, L. Lottonen, M. Merentie, E. Gurzeler, A. Anisimov, A. Miyanohara, K. Alitalo, P. Tavi, and S. Ylä-Herttuala AAV9-mediated VEGF-B gene transfer improves systolic function in progressive left ventricular hypertrophy Mol. Ther. 20 2012 2212 2221
24. R. Kivelä, M. Bry, M.R. Robciuc, M. Räsänen, M. Taavitsainen, J.M. Silvola, A. Saraste, J.J. Hulmi, A. Anisimov, M.I. Mäyränpää, and et al. VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart EMBO Mol. Med. 6 2014 307 321
25. S. Koch, and L. Claesson-Welsh Signal transduction by vascular endothelial growth factor receptors Cold Spring Harb. Perspect. Med. 2 2012 a006502
26. S. Koch, S. Tugues, X. Li, L. Gualandi, and L. Claesson-Welsh Signal transduction by vascular endothelial growth factor receptors Biochem. J. 437 2011 169 183
27. J.E. Lähteenvuo, M.T. Lähteenvuo, A. Kivelä, C. Rosenlew, A. Falkevall, J. Klar, T. Heikura, T.T. Rissanen, E. Vähäkangas, P. Korpisalo, and et al. Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms Circulation 119 2009 845 856
28. X. Li, M. Tjwa, I. Van Hove, B. Enholm, E. Neven, K. Paavonen, M. Jeltsch, T.D. Juan, R.E. Sievers, E. Chorianopoulos, and et al. Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium Arterioscler. Thromb. Vasc. Biol. 28 2008 1614 1620
29. Y. Li, F. Zhang, N. Nagai, Z. Tang, S. Zhang, P. Scotney, J. Lennartsson, C. Zhu, Y. Qu, C. Fang, and et al. VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats J. Clin. Invest. 118 2008 913 923
30. T. Makinen, B. Olofsson, T. Karpanen, U. Hellman, S. Soker, M. Klagsbrun, U. Eriksson, and K. Alitalo Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1 J. Biol. Chem. 274 1999 21217 21222
31. E. Mujagic, R. Gianni-Barrera, M. Trani, A. Patel, L. Gürke, M. Heberer, T. Wolff, and A. Banfi Induction of aberrant vascular growth, but not of normal angiogenesis, by cell-based expression of different doses of human and mouse VEGF is species-dependent Hum. Gene Ther. Methods 24 2013 28 37
32. C. Pellet-Many, P. Frankel, H. Jia, and I. Zachary Neuropilins: structure, function and role in disease Biochem. J. 411 2008 211 226
33. M. Pepe, M. Mamdani, L. Zentilin, A. Csiszar, K. Qanud, S. Zacchigna, Z. Ungvari, U. Puligadda, S. Moimas, X. Xu, and et al. Intramyocardial VEGF-B167 gene delivery delays the progression towards congestive failure in dogs with pacing-induced dilated cardiomyopathy Circ. Res. 106 2010 1893 1903
34. E.D. Rosen, and B.M. Spiegelman What we talk about when we talk about fat Cell 156 2014 20 44
35. R. Serpi, A.M. Tolonen, J. Huusko, J. Rysä, O. Tenhunen, S. Ylä-Herttuala, and H. Ruskoaho Vascular endothelial growth factor-B gene transfer prevents angiotensin II-induced diastolic dysfunction via proliferation and capillary dilatation in rats Cardiovasc. Res. 89 2011 204 213
36. J. Shearer, K.R. Coenen, R.R. Pencek, L.L. Swift, D.H. Wasserman, and J.N. Rottman Long chain fatty acid uptake in vivo: comparison of [125I]-BMIPP and [3H]-bromopalmitate Lipids 43 2008 703 711
37. M. Shibuya Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases J. Biochem. 153 2013 13 19
38. M. Shibuya, and L. Claesson-Welsh Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis Exp. Cell Res. 312 2006 549 560
39. D. Shungin, T.W. Winkler, D.C. Croteau-Chonka, T. Ferreira, A.E. Locke, R. Mägi, R.J. Strawbridge, T.H. Pers, K. Fischer, A.E. Justice, et al. ADIPOGen Consortium CARDIOGRAMplusC4D Consortium CKDGen Consortium GEFOS Consortium GENIE Consortium GLGC ICBP International Endogene Consortium LifeLines Cohort Study MAGIC Investigators MuTHER Consortium PAGE Consortium ReproGen Consortium New genetic loci link adipose and insulin biology to body fat distribution Nature 518 2015 187 196
40. R.E. Soccio, E.R. Chen, and M.A. Lazar Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes Cell Metab. 20 2014 573 591
41. K.B. Sotiropoulos, A. Clermont, Y. Yasuda, C. Rask-Madsen, M. Mastumoto, J. Takahashi, K. Della Vecchia, T. Kondo, L.P. Aiello, and G.L. King Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation: novel mechanism for PPARgamma agonist's effects on edema and weight gain FASEB J. 20 2006 1203 1205
42. K. Sun, I. Wernstedt Asterholm, C.M. Kusminski, A.C. Bueno, Z.V. Wang, J.W. Pollard, R.A. Brekken, and P.E. Scherer Dichotomous effects of VEGF-A on adipose tissue dysfunction Proc. Natl. Acad. Sci. USA 109 2012 5874 5879
43. K. Sun, C.M. Kusminski, K. Luby-Phelps, S.B. Spurgin, Y.A. An, Q.A. Wang, W.L. Holland, and P.E. Scherer Brown adipose tissue derived VEGF-A modulates cold tolerance and energy expenditure Mol. Metab. 3 2014 474 483
44. Y. Sun, K. Jin, J.T. Childs, L. Xie, X.O. Mao, and D.A. Greenberg Increased severity of cerebral ischemic injury in vascular endothelial growth factor-B-deficient mice J. Cereb. Blood Flow Metab. 24 2004 1146 1152
45. H.K. Sung, K.O. Doh, J.E. Son, J.G. Park, Y. Bae, S. Choi, S.M. Nelson, R. Cowling, K. Nagy, I.P. Michael, and et al. Adipose vascular endothelial growth factor regulates metabolic homeostasis through angiogenesis Cell Metab. 17 2013 61 72
46. 3 Leiden.CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome Diabetes Obes. Metab. 16 2014 537 544
47. T.H. van Dijk, A.J. Laskewitz, A. Grefhorst, T.S. Boer, V.W. Bloks, F. Kuipers, A.K. Groen, and D.J. Reijngoud A novel approach to monitor glucose metabolism using stable isotopically labelled glucose in longitudinal studies in mice Lab. Anim. 47 2013 79 88
48. S. Virtue, and A. Vidal-Puig Adipose tissue expandability, lipotoxicity and the metabolic syndrome - an allostatic perspective Biochim. Biophys. Acta 1801 2010 338 349
49. K. Wei, S.M. Piecewicz, L.M. McGinnis, C.M. Taniguchi, S.J. Wiegand, K. Anderson, C.W. Chan, K.X. Mulligan, D. Kuo, J. Yuan, and et al. A liver Hif-2alpha-Irs2 pathway sensitizes hepatic insulin signaling and is modulated by Vegf inhibition Nat. Med. 19 2013 1331 1337
50. R.R. Wing, P. Bolin, F.L. Brancati, G.A. Bray, J.M. Clark, M. Coday, R.S. Crow, J.M. Curtis, C.M. Egan, M.A. Espeland, et al. Look AHEAD Research Group Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes N. Engl. J. Med. 369 2013 145 154
51. L. Zentilin, U. Puligadda, V. Lionetti, S. Zacchigna, C. Collesi, L. Pattarini, G. Ruozi, S. Camporesi, G. Sinagra, M. Pepe, and et al. Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction FASEB J. 24 2010 1467 1478
52. C. Zheng, and Z. Liu Vascular function, insulin action, and exercise: an intricate interplay Trends Endocrinol. Metab. 26 2015 297 304